series-a
Stage
About
Ouro Medicines is a biotechnology company developing immune-reset therapeutics aimed at restoring immune balance in patients with chronic autoimmune and immune-mediated diseases, advancing clinical-stage programs like OM336.
Explore Ouro Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.